Cargando…
The Effect of Metformin on Mortality Among Diabetic Cancer Patients: A Systematic Review and Meta-analysis
BACKGROUND: Most data suggest that cancer patients with diabetes have worse outcomes, which may be reversed with metformin. Metformin might modulate the clinical outcomes of diabetic cancer patients. We performed a systematic review and meta-analysis based on published studies over the past five yea...
Autores principales: | Cao, Xun, Wu, Yaopan, Wang, Jing, Liu, Kuiyuan, Wang, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649807/ https://www.ncbi.nlm.nih.gov/pubmed/31360833 http://dx.doi.org/10.1093/jncics/pkx007 |
Ejemplares similares
-
Metformin use and survival outcomes in endometrial cancer: a systematic review and meta-analysis
por: Xie, Weimin, et al.
Publicado: (2017) -
Prognostic role of metformin in diabetes mellitus type 2 patients with hepatocellular carcinoma: A systematic review and meta-analysis
por: Cigrovski Berkovic, Maja, et al.
Publicado: (2023) -
The impact of metformin use on survival in prostate cancer: a systematic review and meta-analysis
por: Xiao, Yao, et al.
Publicado: (2017) -
Does metformin affect outcomes in COVID‐19 patients with new or pre‐existing diabetes mellitus? A systematic review and meta‐analysis
por: Ganesh, Adithan, et al.
Publicado: (2022) -
The association between metformin use and colorectal cancer survival among patients with diabetes mellitus: An updated meta-analysis
por: Tian, Shan, et al.
Publicado: (2017)